Trials / Completed
CompletedNCT05210634
Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of CHI-915 in Healthy Participants
A Two-Phase, Randomized, Double-Blind, PlaceboControlled Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of CHI-915 in Healthy Participants
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 21 (actual)
- Sponsor
- Canopy Growth Corporation · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This is a two-phase, randomized, double-blind, placebo-controlled, within-participant crossover study to assess the safety, tolerability, PK, and PD of five oral doses of CHI-915 versus placebo in healthy adult participants ages 18-55 years.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | THCv | THCv in MCT oil |
Timeline
- Start date
- 2022-01-11
- Primary completion
- 2022-05-06
- Completion
- 2022-05-06
- First posted
- 2022-01-27
- Last updated
- 2022-05-13
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05210634. Inclusion in this directory is not an endorsement.